ASP1517
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for ASP1517, covering 2010-06-22 to 2024-10-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia [Phase 3]